Insider trading

Period: 120 months Stock: TVRD Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

148 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

148 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

148 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

148 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
148 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
148 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

148 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Mar 2023
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$66.05K 6,802 at 9.71
4.1%
3 Mar 2023
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$60.75K 6,256 at 9.71
6.3%
3 Mar 2023
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$60.41K 6,221 at 9.71
9.6%
3 Mar 2023
Posner Christopher President and CEO
Sold, plan not stated
$58.13K 5,987 at 9.71
3.3%
16 Feb 2023
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$23.10K 2,265 at 10.20
3.4%
2 Feb 2023
Posner Christopher President and CEO
Sold, plan not stated
$49.45K 4,191 at 11.80
2.2%
17 Jan 2023
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$24.48K 2,265 at 10.81
3.3%
29 Dec 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$23.06K 2,265 at 10.18
3.2%
21 Dec 2022
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$39.51K 3,506 at 11.27
2.1%
21 Dec 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$33.72K 2,992 at 11.27
4.0%
21 Dec 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$28.86K 2,561 at 11.27
2.5%
16 Nov 2022
Posner Christopher President and CEO
Sold, plan not stated
$161.05K 14,470 at 11.13
7.2%
14 Sep 2022
VOGELBAUM MARTIN Director
Sold, plan not stated
$111.02K 10,800 at 10.28
19.4%
15 Jul 2022
Sold, plan not stated
$65.16K 7,200 at 9.05
22.3%
15 Jul 2022
Ives Jeffrey L. Director
Sold, plan not stated
$32.58K 3,600 at 9.05
18.9%
4 Apr 2022
Posner Christopher President and CEO
Sold, plan not stated
$25.42K 2,006 at 12.67
1.0%
1 Apr 2022
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$21.25K 1,784 at 11.91
1.0%
1 Apr 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$19.56K 1,642 at 11.91
2.1%
1 Apr 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$19.56K 1,642 at 11.91
1.6%
3 Mar 2022
Reilly Thomas Charles Chief Financial Officer
Sold, plan not stated
$23.26K 2,044 at 11.38
5.1%
3 Mar 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$20.34K 1,787 at 11.38
1.7%
25 Feb 2022
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$21.75K 2,114 at 10.29
1.2%
25 Feb 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$20.29K 1,972 at 10.29
2.5%
25 Feb 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$20.29K 1,972 at 10.29
1.9%
12 Nov 2021
Ives Jeffrey L. Director
Sold, plan not stated
$131.21K 8,180 at 16.04
53.2%
Sold half or more
1 Nov 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$17.15K 1,000 at 17.15
2.1%
27 Oct 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$15.00K 1,000 at 15.00
2.1%
7 Sep 2021
CHALMERS DEREK T President & CEO
Sold, plan not stated
$309.40K 20,000 at 15.47
2.0%
30 Aug 2021
CHALMERS DEREK T President & CEO
Sold, plan not stated
$119.85K 8,440 at 14.20
0.8%
30 Aug 2021
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$54.63K 3,847 at 14.20
2.7%
30 Aug 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$29.96K 2,110 at 14.20
4.2%
30 Aug 2021
Reilly Thomas Charles Chief Financial Officer
Sold, plan not stated
$28.14K 1,982 at 14.20
37.2%
30 Aug 2021
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$24.98K 1,759 at 14.20
2.4%
7 Jun 2021
VOGELBAUM MARTIN Director
Sold, plan not stated
$112.75K 8,640 at 13.05
30.0%
7 Jun 2021
Ives Jeffrey L. Director
Sold, plan not stated
$32.89K 2,520 at 13.05
14.1%
7 Jun 2021
Sold, plan not stated
$30.04K 2,304 at 13.04
12.5%
21 Apr 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$82.89K 3,000 at 27.63
6.4%
22 Mar 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$58.95K 3,000 at 19.65
8.9%
5 Mar 2021
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$60.38K 3,358 at 17.98
2.7%
5 Mar 2021
CHALMERS DEREK T President & CEO
Sold, plan not stated
$55.79K 3,103 at 17.98
0.3%
5 Mar 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$55.61K 3,093 at 17.98
8.4%
5 Mar 2021
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$55.56K 3,090 at 17.98
5.7%
25 Feb 2021
CHALMERS DEREK T President & CEO
Sold, plan not stated
$226.72K 11,729 at 19.33
1.2%
25 Feb 2021
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$96.71K 5,003 at 19.33
4.3%
25 Feb 2021
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$77.40K 4,004 at 19.33
8.3%
25 Feb 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$65.18K 3,372 at 19.33
11.2%
22 Feb 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$39.46K 2,000 at 19.73
7.1%
21 Jan 2021
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$40.24K 2,000 at 20.12
6.7%
30 Dec 2020
CHALMERS DEREK T President & CEO
Sold, plan not stated
$92.99K 6,078 at 15.30
0.6%
30 Dec 2020
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$43.02K 2,812 at 15.30
2.5%
Showing 1–50 of 148. Page 1 of 3 Older →